Clinical TrialsSearch results
Number of results: 1190
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A study to test whether different doses of BI 456906 are effective in people with a liver disease called non-alcoholic steatohepatitis (NASH) and liver fibrosis
- Non-alcoholic steatohepatitis
- Kenmochi Hiroki
- 2021-06-14
Completed
- A study on the safety and efficacy of a dilator for recanalization therapy for major cerebral artery occlusion
- acute ischemic stroke
- Sakai Nobuyuki
- 2022-10-05
Completed
- A study of the effectiveness of maintenance treatment with adapalene 0.1%-benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel in acne vulgaris patients
- Acne vulgaris
- Tanizaki Hideaki
- 2020-07-20
Completed
- A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination with Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
- Mantle cell lymphoma
- Fujikawa Ei
- 2023-04-16
Completed
- A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
- Lennox-Gastaut Syndrome
- Nonomura Hidenori
- 2021-09-04
Completed
- A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome
- Dravet Syndrome
- Nonomura Hidenori
- 2021-09-04
Completed
- A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis
- Nonalcoholic Steatohepatitis
- Tanaka Yoshiyuki
- 2020-11-10
Completed
- A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
- *Dilated Cardiomyopathy *Lamin A/C Gene Mutation
- Kawai Norisuke
- 2022-03-09
Completed
- A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly semaglutide (COMBINE 2)
- type 2 diabetes
- Miwa Hirotaka
- 2022-06-10
Completed
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Three-way Crossover Trial to Evaluate the Efficacy and Safety of Two Dose Levels of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II
- Hereditary Angioedema
- Smith Michael
- 2023-02-28